Improving access to medicines via the Health Impact Fund in India: a stakeholder analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Improving access to medicines via the Health Impact Fund in India: a stakeholder analysis

Published:2018-01 Issue:1 Volume:11 Page:1434935
ISSN:1654-9716
Container-title:Global Health Action
language:en
Short-container-title:Global Health Action

Author:

McMullan Patrick¹,Ajay Vamadevan S.²^ORCID,Srinivas Ravi³,Bhalla Sandeep⁴,Prabhakaran Dorairaj²,Banerjee Amitava⁵⁶⁷^ORCID

Affiliation:

1. University of Birmingham Medical School, Birmingham, UK

2. Health System Unit, Centre for Chronic Disease Control, New Delhi, India

3. Research and Information Systems for Developing Countries (RIS), New Delhi, India

4. Training Division, Public Health Foundation of India, New Delhi, India

5. University of Birmingham Centre for Cardiovascular Sciences, Birmingham, UK

6. Farr Institute of Health Informatics Research, University College London, London, UK

7. School of Health, University of Central Lancashire, Preston, UK

Funder

Wolfson Foundation

Arthur Thompson Trust

European Research Council

FP7 Ideas: European Research Council

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/16549716.2018.1434935

Reference45 articles.

1. Access to medicines from a health system perspective

2. Policy approaches to improve availability and affordability of medicines in Mexico – an example of a middle income country

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospects and Challenges of Generic Medicines Adoption in India: Consumer and Physician Perspectives;International Journal of Life Science and Pharma Research;2022-07-29

2. Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis;Health Research Policy and Systems;2021-12

3. The Coronavirus Pandemic: The Growing Relevance of Moral Cosmopolitan Justice?;Fudan Journal of the Humanities and Social Sciences;2021-10-23

4. Human rights obligations of drug companies;Journal of Human Rights;2020-10-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3